Clinical Trial

A Study of MHB118C Injection in Patients With Advanced Solid Tumors

Name: A Study of MHB118C Injection in Patients With Advanced Solid Tumors — clinical trial record (NCT07045454)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a first-in-human, open-label, multicenter Phase I study of MHB118C in patients with advanced solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of MHB118C monotherapy.

Trial Details

NCT Number	NCT07045454
Lead Sponsor	Minghui Pharmaceutical (Hangzhou) Ltd
Conditions	Advanced Malignant Solid Tumor
Enrollment	200 participants
Start Date	2025-03-31
Primary Completion	2029-03 (estimated)
Study Completion	2031-03 (estimated)
Updated on ClinicalTrials.gov	2025-07-01